Alkermes PLC (ALKS) Stock Price, Quote, News & History

ALKSNASDAQ
$41.75
-0.44-1.04%
Last update: Jun 1, 9:39 AM
20%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
256.20M
Investing Cash Flow (TTM)
-1.79B
Financing Cash Flow (TTM)
1.49B
Free Cash Flow (TTM)
221.80M
Capital Expenditure (TTM)
-34.40M
Net Change in Cash (TTM)
-48.26M

Analyst Trends and Forecast

3
1
Feb
1
Mar
1
Apr
4
May
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$8.10B
PE Ratio (TTM)
46.88
PE Ratio (FWD)
111.11
PEG Ratio (TTM)
-
PS Ratio (TTM)
4.54
PB Ratio (TTM)
4.01
Earnings Yield % (TTM)
2.13%
Earnings Yield % (FWD)
0.90%
EV / EBITDA (TTM)
29.31
Price / EBITDA (TTM)
25.66
Price / Free Cash Flow (TTM)
31.98
Book Value / Share
$10.51

Company Debt

Total Debt
$1.51B
LT Debt
$1.48B
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$351.55M
Debt to Equity
0.90
Issuance of Debt (TTM)
$1.51B
Repayment of Debt (TTM)
-

Key Statistics

Open
$42.19
Close
-
Volume / Avg.
93.13K / 2.37M
Day Range
$41.50 - $42.19
52 Wk Range
25.17 - 42.83
Market Cap
$6.96B
P/E Ratio
46.88
Dividend Yield
-
Exchange
NASDAQ
RSI
75
Short Interest
15.23%
Days to Cover
7.55

About

Sector
Health Care
Industry
Biotechnology
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Alkermes (ALKS) stock?

A

You can purchase shares of Alkermes (NASDAQ:ALKS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Alkermes (ALKS) competitors?

A

There are no as such competitors for Alkermes.

Q

What is the forecast, or price target, for Alkermes (ALKS) stock?

A

Alkermes has a consensus price target of $43.32.

Q

What is the current price for Alkermes (ALKS)?

A

The stock price for Alkermes (NASDAQ: ALKS) is $41.75 last updated June 1, 2026 at 9:39 AM EDT.

Q

Does Alkermes (ALKS) pay a dividend?

A

There are no upcoming dividends for Alkermes.

Q

When is Alkermes (NASDAQ:ALKS) reporting earnings?

A

Alkermes does not have any upcoming earnings scheduled.

Q

Is Alkermes (ALKS) going to split?

A

There is no upcoming split for Alkermes.

Q

What sector and industry does Alkermes (ALKS) operate in?

A

Alkermes is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.